Company Filing History:
Years Active: 2016
Title: Petra Keul: Innovator in S1P Receptor Targeting
Introduction
Petra Keul is a prominent inventor based in Duesseldorf, Germany. She has made significant contributions to the field of biomedical research, particularly in the area of S1P receptor targeting. Her innovative work focuses on the development of novel compounds that can aid in the diagnosis and treatment of various diseases.
Latest Patents
Petra Keul holds a patent for "Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases." This invention relates to novel compounds of formulae (I) and (II) that are useful in the prevention, treatment, and diagnosis of diseases associated with S1P receptors. These diseases include inflammation, pain, autoimmune disorders, and cardiovascular diseases. She has 1 patent to her name.
Career Highlights
Petra Keul is affiliated with the Westfälische Wilhelms-Universität Münster, where she conducts her research. Her work has garnered attention for its potential impact on medical science and patient care.
Collaborations
Throughout her career, Petra has collaborated with notable colleagues, including Guenter Haufe and Bodo Levkau. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.
Conclusion
Petra Keul is a trailblazer in the field of S1P receptor research, with a focus on developing compounds that can significantly improve disease diagnosis and treatment. Her contributions are paving the way for future advancements in medical science.